Diabetes management requires a careful balance of medication, diet, and lifestyle. GLICLAGLAZE TRIO 0.3, containing Voglibose 0.3mg, Metformin 500mg, and Gliclazide 80mg, is a potent combination therapy designed for patients with type 2 diabetes who need effective glycemic control. This triple-action tablet works synergistically to target multiple pathways in blood sugar regulation, helping patients maintain optimal glucose levels and reduce the risk of complications.
Manufactured by Steris Healthcare Pvt. Ltd., a trusted name in the pharmaceutical industry, GLICLAGLAZE TRIO 0.3 combines safety, efficacy, and convenience, offering a reliable option for both newly diagnosed and long-term diabetes patients.
What is GLICLAGLAZE TRIO 0.3?
GLICLAGLAZE TRIO 0.3 is an oral anti-diabetic medication that combines three active agents:
Voglibose (0.3mg): An alpha-glucosidase inhibitor that delays carbohydrate absorption in the intestines, reducing post-meal blood sugar spikes.
Metformin (500mg): A biguanide that decreases liver glucose production and improves insulin sensitivity in peripheral tissues.
Gliclazide (80mg): A sulfonylurea that stimulates the pancreas to release insulin, lowering blood sugar levels.
By targeting different mechanisms of blood sugar regulation, GLICLAGLAZE TRIO 0.3 provides comprehensive glycemic control for type 2 diabetes patients.
Uses of Voglibose, Metformin & Gliclazide Combination
The triple combination of GLICLAGLAZE TRIO 0.3 is effective for:
Type 2 Diabetes Management: Helps maintain fasting and postprandial blood glucose levels.
Post-Meal Sugar Control: Voglibose prevents rapid spikes in blood sugar after meals.
Insulin Sensitivity Improvement: Metformin enhances the body’s response to insulin.
Pancreatic Support: Gliclazide stimulates insulin secretion to regulate glucose levels effectively.
Preventing Complications: Proper glycemic control reduces the risk of neuropathy, retinopathy, and kidney damage.
This combination therapy ensures patients experience balanced blood sugar levels throughout the day.
How GLICLAGLAZE TRIO 0.3 Works
The medication works through three complementary mechanisms:
Voglibose: Slows carbohydrate absorption in the intestines, preventing rapid postprandial glucose increases.
Metformin: Reduces hepatic glucose production and improves peripheral glucose utilization, controlling fasting blood sugar.
Gliclazide: Stimulates pancreatic beta cells to secrete insulin, lowering blood sugar after meals.
Together, these actions provide a dual-phase approach for both fasting and post-meal glucose control, addressing the root causes of type 2 diabetes.
Dosage and Administration
The dosage of GLICLAGLAZE TRIO 0.3 should be individualized based on patient needs and blood sugar levels:
Typically taken once daily before meals or as prescribed by a healthcare professional.
Swallow the tablet whole with water; do not crush or chew.
Regular monitoring of blood glucose is essential to ensure the medication is effective.
Do not adjust the dose without consulting your doctor.
Possible Side Effects
GLICLAGLAZE TRIO 0.3 is generally well-tolerated, but some patients may experience mild side effects:
Nausea, vomiting, or upset stomach
Diarrhea or abdominal discomfort
Hypoglycemia (low blood sugar) – symptoms include sweating, shakiness, confusion, and dizziness
Mild headache or fatigue
Serious side effects are rare but may include:
Severe hypoglycemia
Allergic reactions (rash, itching, swelling)
Liver or kidney dysfunction
Patients should seek medical attention if they experience unusual or persistent symptoms.
Precautions and Safety Information
Before using GLICLAGLAZE TRIO 0.3, patients should consider:
Inform your doctor if you have kidney, liver, or heart issues.
Monitor blood sugar regularly, especially during illness or dietary changes.
Pregnant or breastfeeding women should use only under medical supervision.
Maintain a balanced diet and regular exercise routine for optimal results.
Avoid alcohol, which may increase the risk of hypoglycemia.
Why Choose Steris Healthcare Pvt. Ltd.?
Steris Healthcare is a leading pharmaceutical company known for quality, innovation, and patient safety. Choosing GLICLAGLAZE TRIO 0.3 from Steris Healthcare ensures:
WHO-GMP Certified Manufacturing: Adherence to international quality standards.
Clinically Proven Formulation: Effective glycemic control with triple-action therapy.
Patient-Centric Approach: Formulated for convenience and improved adherence.
Reliable & Accessible: Widely available across India at competitive pricing.
Trusted Brand Reputation: Steris Healthcare is recognized for producing safe, high-quality medications.
Tips for Patients Taking GLICLAGLAZE TRIO 0.3
To maximize the benefits of this combination therapy:
Take the medication regularly at the same time daily.
Maintain a healthy diet and follow the exercise plan recommended by your doctor.
Monitor blood glucose frequently and keep a record to track progress.
Avoid skipping meals to prevent hypoglycemia.
Report any unusual symptoms or side effects to your healthcare provider immediately.
Frequently Asked Questions
1. What is GLICLAGLAZE TRIO 0.3 used for?
It is used to manage type 2 diabetes by controlling both fasting and postprandial blood sugar levels.
2. Can this tablet cause low blood sugar?
Yes, hypoglycemia may occur, especially if meals are skipped. Signs include sweating, shakiness, or confusion.
3. Can it be used long-term?
Yes, under medical supervision, it can be used as a long-term solution for type 2 diabetes management.
4. What should I do if I miss a dose?
Take it as soon as you remember unless it’s almost time for the next dose. Do not double the dose.
5. Can GLICLAGLAZE TRIO 0.3 be used during pregnancy?
Only under medical supervision. Consult your doctor if you are pregnant or breastfeeding.
6. How should I store the medication?
Keep it in a cool, dry place away from direct sunlight and out of reach of children.
Conclusion
GLICLAGLAZE TRIO 0.3 is a triple-action oral anti-diabetic medication combining Voglibose 0.3mg, Metformin 500mg, and Gliclazide 80mg. It provides comprehensive control of both fasting and post-meal blood sugar levels, addressing multiple mechanisms of type 2 diabetes.
Manufactured by Steris Healthcare Pvt. Ltd., a trusted and WHO-GMP-certified pharmaceutical company, this combination tablet ensures safety, efficacy, and patient convenience. For patients seeking effective, reliable, and clinically proven diabetes management, GLICLAGLAZE TRIO 0.3 is a valuable solution to maintain glycemic control and improve quality of life.
📩 For further information, email: info@sterispharma.com / contact@sterispharma.com
📞 Call/WhatsApp: 8209542042, 8824175417
👉
